Connection

Michael Madaio to Humans

This is a "connection" page, showing publications Michael Madaio has written about Humans.
Connection Strength

0.378
  1. The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis. Kidney Int. 2019 06; 95(6):1359-1372.
    View in: PubMed
    Score: 0.026
  2. Kidney-targeted inhibition of protein kinase C-a ameliorates nephrotoxic nephritis with restoration of mitochondrial dysfunction. Kidney Int. 2018 08; 94(2):280-291.
    View in: PubMed
    Score: 0.024
  3. Human anti-a3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis. Am J Physiol Renal Physiol. 2015 Oct 15; 309(8):F680-4.
    View in: PubMed
    Score: 0.020
  4. A human monoclonal antibody against the collagen type IV a3NC1 domain is a non-invasive optical biomarker for glomerular diseases. Kidney Int. 2013 Aug; 84(2):403-8.
    View in: PubMed
    Score: 0.017
  5. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics. 2011 Jan; 6(1):20-8.
    View in: PubMed
    Score: 0.015
  6. Biomarkers in lupus nephritis. Rheum Dis Clin North Am. 2010 Feb; 36(1):131-43, ix.
    View in: PubMed
    Score: 0.014
  7. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Am J Nephrol. 2009; 30(5):474-80.
    View in: PubMed
    Score: 0.013
  8. Pathogenic autoantibodies in lupus nephritis. Lupus. 2005; 14(1):19-24.
    View in: PubMed
    Score: 0.010
  9. Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin Nephrol. 2003 Nov; 23(6):564-8.
    View in: PubMed
    Score: 0.009
  10. The role of antibodies and B cells in the pathogenesis of lupus nephritis. Springer Semin Immunopathol. 2003 May; 24(4):363-75.
    View in: PubMed
    Score: 0.009
  11. Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity. Clin Exp Immunol. 2003 Mar; 131(3):396-7.
    View in: PubMed
    Score: 0.009
  12. Structural considerations of autoantibodies. Lupus. 2002; 11(12):774-5.
    View in: PubMed
    Score: 0.008
  13. SARS-CoV-2 Reinfection in a Liver Transplant Recipient. Ann Intern Med. 2021 08; 174(8):1178-1180.
    View in: PubMed
    Score: 0.007
  14. The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Arch Intern Med. 2001 Jan 08; 161(1):25-34.
    View in: PubMed
    Score: 0.007
  15. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int. 2000 Jul; 58(1):115-22.
    View in: PubMed
    Score: 0.007
  16. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. Am J Kidney Dis. 2000 May; 35(5):992-6.
    View in: PubMed
    Score: 0.007
  17. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol. 1999 Jan; 19(1):48-56.
    View in: PubMed
    Score: 0.006
  18. Training the physician-scientist: views from program directors and aspiring young investigators. JCI Insight. 2018 12 06; 3(23).
    View in: PubMed
    Score: 0.006
  19. Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications. J Autoimmun. 1998 Oct; 11(5):535-8.
    View in: PubMed
    Score: 0.006
  20. Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans. Nat Immunol. 2018 06; 19(6):571-582.
    View in: PubMed
    Score: 0.006
  21. iRhom2 promotes lupus nephritis through TNF-a and EGFR signaling. J Clin Invest. 2018 04 02; 128(4):1397-1412.
    View in: PubMed
    Score: 0.006
  22. Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine. Am J Med. 2018 05; 131(5):578-584.
    View in: PubMed
    Score: 0.006
  23. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int. 1998 Feb; 53(2):402-7.
    View in: PubMed
    Score: 0.006
  24. B cells and autoantibodies in the pathogenesis of lupus nephritis. Immunol Res. 1998; 17(1-2):123-32.
    View in: PubMed
    Score: 0.006
  25. Estrogen Receptor a Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity. J Immunol. 2018 01 15; 200(2):512-522.
    View in: PubMed
    Score: 0.006
  26. Are DNA antibodies actually pathogenic? Lupus. 1997; 6(3):307-9.
    View in: PubMed
    Score: 0.006
  27. Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol. 1996 Dec; 26(12):3035-41.
    View in: PubMed
    Score: 0.006
  28. Cumulative impact of periodic top-down communications on infection prevention practices and outcomes in two units. Health Care Manage Rev. 2015 Oct-Dec; 40(4):324-36.
    View in: PubMed
    Score: 0.005
  29. Amino acid metabolism inhibits antibody-driven kidney injury by inducing autophagy. J Immunol. 2015 Jun 15; 194(12):5713-24.
    View in: PubMed
    Score: 0.005
  30. The evolution of knowledge exchanges enabling successful practice change in two intensive care units. Health Care Manage Rev. 2015 Jan-Mar; 40(1):65-78.
    View in: PubMed
    Score: 0.005
  31. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: a-enolase and annexin AI. J Am Soc Nephrol. 2014 Nov; 25(11):2483-98.
    View in: PubMed
    Score: 0.005
  32. Structural properties of a subset of nephritogenic anti-DNA antibodies. Immunol Res. 1994; 13(2-3):172-85.
    View in: PubMed
    Score: 0.005
  33. Role of communication content and frequency in enabling evidence-based practices. Qual Manag Health Care. 2014 Jan-Mar; 23(1):43-58.
    View in: PubMed
    Score: 0.005
  34. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest. 1993 Nov; 69(5):494-507.
    View in: PubMed
    Score: 0.004
  35. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann Rheum Dis. 2014 Oct; 73(10):1888-97.
    View in: PubMed
    Score: 0.004
  36. The nephritogenic immune response. Curr Opin Nephrol Hypertens. 1993 May; 2(3):441-8.
    View in: PubMed
    Score: 0.004
  37. Cyclophosphamide in progressive membranous glomerulopathy: pro and con. Ann Intern Med. 1992 Oct 15; 117(8):696; author reply 697.
    View in: PubMed
    Score: 0.004
  38. Anti-DNA idiotype network: therapeutic considerations. Lupus. 1992 Oct; 1(5):339-40.
    View in: PubMed
    Score: 0.004
  39. Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions. J Immunol. 1990 Dec 15; 145(12):4229-37.
    View in: PubMed
    Score: 0.004
  40. Renal biopsy. Kidney Int. 1990 Sep; 38(3):529-43.
    View in: PubMed
    Score: 0.004
  41. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun. 1990 Apr; 3(2):215-35.
    View in: PubMed
    Score: 0.003
  42. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol. 1989 Jan; 19(1):137-43.
    View in: PubMed
    Score: 0.003
  43. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum. 2008 Jun; 58(6):1789-95.
    View in: PubMed
    Score: 0.003
  44. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum. 2008 Jun; 58(6):1784-8.
    View in: PubMed
    Score: 0.003
  45. Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Evidence of in situ immune complex formation on the platelet surface. Transplantation. 1988 Mar; 45(3):647-9.
    View in: PubMed
    Score: 0.003
  46. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol. 2007 Sep; 2(5):1054-61.
    View in: PubMed
    Score: 0.003
  47. Lupus serum and normal human serum contain anti-DNA antibodies with the same idiotypic marker. J Immunol. 1986 Oct 15; 137(8):2535-40.
    View in: PubMed
    Score: 0.003
  48. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med. 2006 Mar 20; 203(3):789-97.
    View in: PubMed
    Score: 0.003
  49. Current concepts. The diagnosis of acute glomerulonephritis. N Engl J Med. 1983 Nov 24; 309(21):1299-302.
    View in: PubMed
    Score: 0.002
  50. Studies of experimental membranous nephropathy. Transplant Proc. 1982 Sep; 14(3):474-81.
    View in: PubMed
    Score: 0.002
  51. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol. 2002 Sep; 161(3):1077-86.
    View in: PubMed
    Score: 0.002
  52. IL-10 regulates murine lupus. J Immunol. 2002 Aug 15; 169(4):2148-55.
    View in: PubMed
    Score: 0.002
  53. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev. 1999 Jun; 169:107-21.
    View in: PubMed
    Score: 0.002
  54. Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection. Clin Exp Immunol. 1999 Feb; 115(2):275-80.
    View in: PubMed
    Score: 0.002
  55. The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1. J Clin Invest. 1998 Apr 15; 101(8):1699-707.
    View in: PubMed
    Score: 0.002
  56. Vaccination against pathogenic cells by DNA inoculation. Curr Top Microbiol Immunol. 1998; 226:21-35.
    View in: PubMed
    Score: 0.001
  57. Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997 Nov; 8(11):1795-800.
    View in: PubMed
    Score: 0.001
  58. The roles of B cells in MRL/lpr murine lupus. Ann N Y Acad Sci. 1997 Apr 05; 815:75-87.
    View in: PubMed
    Score: 0.001
  59. Murine lupus in the absence of alpha beta T cells. J Immunol. 1996 May 15; 156(10):4041-9.
    View in: PubMed
    Score: 0.001
  60. Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med. 1996 Apr 01; 124(7):651-3.
    View in: PubMed
    Score: 0.001
  61. Anti-DNA antibodies bind to DNase I. J Exp Med. 1995 May 01; 181(5):1797-804.
    View in: PubMed
    Score: 0.001
  62. Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus. Nephron. 1995; 69(2):140-6.
    View in: PubMed
    Score: 0.001
  63. Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis. 1991 Feb; 17(2):199-205.
    View in: PubMed
    Score: 0.001
  64. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum. 1990 Oct; 33(10):1554-9.
    View in: PubMed
    Score: 0.001
  65. Restriction fragment length polymorphism analysis of the V kappa locus in human lupus. Eur J Immunol. 1989 Sep; 19(9):1757-60.
    View in: PubMed
    Score: 0.001
  66. Enalapril in the management of hypertension associated with renal artery stenosis. J Clin Pharmacol. 1987 Jan; 27(1):32-40.
    View in: PubMed
    Score: 0.001
  67. Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med. 1985 Jun 01; 161(6):1525-38.
    View in: PubMed
    Score: 0.001
  68. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet. 1984 Aug 25; 2(8400):417-22.
    View in: PubMed
    Score: 0.001
  69. Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med. 1983 Sep 01; 158(3):718-30.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.